About Biomaxx
Built for researchers who need data they can trust.
Biomaxx was founded on a simple frustration: too many suppliers in the research peptide space make claims they can't substantiate. Purity figures without test data. Stock levels that are fiction. Compounds of unknown origin, dressed up in credible packaging.
Why we exist
The research peptide market occupies an unusual space. The compounds are real — many have substantial preclinical literature and some have progressed to human trials. But the supply chain has always been opaque, and the gap between what suppliers claim and what their products actually contain has been wide enough to undermine serious research.
We started Biomaxx because we believed that segment of the market could be done better. Not better packaging, not better marketing — better compounds, with the documentation to prove it.
Every product in our catalogue comes from a GMP-compliant synthesis facility and is independently tested by an accredited third-party lab. We publish the real purity figure, not a target. We make Certificates of Analysis available on request. And we will tell you honestly when something is out of stock rather than shipping a short vial and hoping you don't notice.
Our numbers
How we operate
01
Accuracy over marketing
Every number we publish is backed by third-party HPLC data. We do not round up purity scores, inflate stock counts, or use comparative language we cannot substantiate. If the batch doesn't meet our threshold, it doesn't ship.
02
Transparency as standard
Certificates of Analysis are available on request for every batch we sell. The compound, the purity figure, the test date, and the batch number — no redactions, no summaries. The data is the product.
03
Research-first positioning
Biomaxx exists to serve researchers, not to make health claims. Our catalogue, our copy, and our communications are built around that. We will not describe mechanisms as outcomes, and we will not pretend peptide science is settled where it isn't.